These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs. Massart C; Orgiazzi J; Maugendre D Clin Chim Acta; 2001 Feb; 304(1-2):39-47. PubMed ID: 11165197 [TBL] [Abstract][Full Text] [Related]
9. Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves' disease: thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal. Guilhem I; Massart C; Poirier JY; Maugendre D Thyroid; 2006 Oct; 16(10):1041-5. PubMed ID: 17042691 [TBL] [Abstract][Full Text] [Related]
10. Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves' disease. Wright-Pascoe R; Smikle MF; Barton EN; James OB Hum Antibodies; 1999; 9(3):161-4. PubMed ID: 10690629 [TBL] [Abstract][Full Text] [Related]
11. Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease. Massart C; Sonnet E; Gibassier J; Maugendre D; Genetet B Clin Chim Acta; 1997 Sep; 265(2):157-68. PubMed ID: 9385458 [TBL] [Abstract][Full Text] [Related]
12. Is TPO detectable in the circulation? Premawardhana LD; Kiso Y; Phillips DI; Morteo C; Furmaniak J; Rees Smith B Thyroid; 1993; 3(3):225-8. PubMed ID: 8257863 [TBL] [Abstract][Full Text] [Related]
13. Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Engler H; Riesen WF; Keller B Clin Chim Acta; 1994 Mar; 225(2):123-36. PubMed ID: 8088002 [TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase autoantibodies and their effects on enzyme activity in patients with systemic lupus erythematosus. Tsai RT; Chang TC; Wang CR; Lee SL; Wang CJ; Tsay GJ Lupus; 1995 Aug; 4(4):280-5. PubMed ID: 8528224 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of sera concentrations of thyroperoxidase autoantibodies measured by two radioimmunoassays]. Vrndić O; Zivancević-Simonović S; Dimitrijević L; Dukić A; Arsenijević N Med Pregl; 2010; 63(1-2):104-8. PubMed ID: 20873319 [TBL] [Abstract][Full Text] [Related]
16. Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay. Mankaï A; Toumi D; Chadli-Chaieb M; Ghedira-Besbes L; Saad F; Ouertani M; Sfar H; Jeddi M; Chaieb L; Ghedira I Clin Chem Lab Med; 2007; 45(1):26-9. PubMed ID: 17243910 [TBL] [Abstract][Full Text] [Related]
17. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment. Knobel M; Barca MF; Pedrinola F; Medeiros-Neto G J Endocrinol Invest; 1994 Dec; 17(11):837-42. PubMed ID: 7745231 [TBL] [Abstract][Full Text] [Related]
19. Novel routine assay of thyroperoxidase autoantibodies. Ruf J; Czarnocka B; Ferrand M; Doullais F; Carayon P Clin Chem; 1988 Nov; 34(11):2231-4. PubMed ID: 3180414 [TBL] [Abstract][Full Text] [Related]
20. Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease. Massart C; Hody B; Mouchel L; Edan G; Nicol M Clin Chem; 1986 Jul; 32(7):1332-5. PubMed ID: 2872980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]